# Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

> **NCT00613808** · PHASE2 · TERMINATED · sponsor: **Nitric BioTherapeutics, Inc** · enrollment: 6 (actual)

## Conditions studied

- Venous Ulcers

## Interventions

- **DRUG:** Nitric Oxide 200ppm Group B

## Key facts

- **NCT ID:** NCT00613808
- **Lead sponsor:** Nitric BioTherapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2008-11
- **Final completion:** 2009-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613808, "Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00613808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*